FDA Public Workshop: GI Regulatory Endpoints & Advancement Therapeutics

The American College of Gastroenterology (ACG), in partnership with the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, the American Gastroenterological Association, the Crohn’s and Colitis Foundation of America, ...

Gluten-Free Diet and Lipid Profile in Children with Celiac Disease

Poster 572 Gluten-Free Diet and Lipid Profile in Children with Celiac Disease Author insight from Maria Luisa Forchielli, MD, Medical School of Bologna, Italy What’s new here and important for clinicians? Children and adolescents with celiac ...

Not All Diarrhea and Villous Atrophy Is Celiac Disease: A Case Report on Olmesartan-Induced Enteropathy

Poster 1434: Not All Diarrhea and Villous Atrophy Is Celiac Disease: A Case Report on Olmesartan-Induced Enteropathy Abimbola Aderinto-Adike, MD Author Insight from Abimbola Aderinto-Adike, MD, Houston Methodist Hospital What’s new here ...

Increased Risk of Eosinophilic Esophagitis in Patients With Active Celiac Disease on Biopsy: Results From a National Pathology Database

p3 Increased Risk of Eosinophilic Esophagitis in Patients With Active Celiac Disease on Biopsy: Results From a National Pathology Database Elizabeth Jensen, MPH, PhD Author insight from Elizabeth Jensen, MPH PhD, Center for Esophageal Diseases ...

Celiac Disease in Women With Infertility: A Meta-Analysis

P187 Celiac Disease in Women With Infertility: A Meta-Analysis Prashant Singh, MD Author insight from Prashant Singh, MD, Massachusetts General Hospital, Boston What’s new here and important for clinicians? This study confirms an association ...

The Clinical Characteristics of HLA Genotype DQ2.2 in a U.S. Adult Celiac Disease Population

Plenary Session 1: IBD / Small Intestine / Unclassified Wednesday, October 22 8:30 am – 10:15 am Moderators: Francis A. Farraye, MD, MSc, FACG Jonathan A. Leighton MD, FACG Oral 55: The Clinical Characteristics of HLA Genotype DQ2.2 in a U.S. ...